ADMA Biologics, Inc. (ADMA)

19.52 +0.04 (+0.18%) USD  |  NASDAQ  |  Dec 24, 12:59
19.52 0.00 (0.00%) After-Hours: 13:59
More

ADMA Biologics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. --
Arcutis Biotherapeutics, Inc. Upgrade
Exelixis, Inc. Upgrade